Optical and Electrochemical Detection of Prostate Cancer Biomarker PCA3 Using Specific Aptasensor

TAKITA, Sarra (2026). Optical and Electrochemical Detection of Prostate Cancer Biomarker PCA3 Using Specific Aptasensor. Doctoral, Sheffield Hallam University. [Thesis]

Documents
38101:1432126
[thumbnail of Takita_2026_PhD_OpticalAndElectrochemical.pdf]
Preview
PDF
Takita_2026_PhD_OpticalAndElectrochemical.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (14MB) | Preview
Abstract
Prostate cancer (PCa) is one of the most prevalent malignancies among men worldwide. Although prostate-specific antigen (PSA) testing has improved early detection of PCa, its limited specificity leads to false positives and false negatives, resulting in overdiagnosis and unnecessary biopsies. These limitations highlight the need for more accurate, specific, and non-invasive biomarkers to improve PCa diagnosis. Prostate Cancer Antigen 3 (PCA3), a long non-coding RNA markedly overexpressed in malignant prostate tissue and detectable in urine, offers improved diagnostic specificity. However, commercial PCA3 tests, such as Progensa®, remain complex, costly, and unsuitable for broad clinical implementation and accessibility, underscoring the need for simple, sensitive, and non-invasive diagnostic tools for PCa detection. This thesis presents the development and optimisation of novel aptamer-based biosensing platforms (aptasensors) for sensitive and selective detection of PCA3. Using the CG3 RNA aptamer, several electrochemical and optical detection strategies were investigated, including cyclic voltammetry (CV), differential pulse voltammetry (DPV), electrochemical impedance spectroscopy (EIS), and total internal reflection ellipsometry (TIRE). Both redox labelled (ferrocene and methylene blue) and label-free RNA aptamer formats were immobilised onto a range of nanostructured gold transducers, including screen-printed gold electrodes (SPGE) and gold nanoparticle-modified carbon electrodes (AuNP/SPCE). The sensing platforms demonstrated progressive improvements in detection sensitivity, with the most advanced label-free EIS-based aptasensor achieving detection limits of 1 fM in buffer and 20 fM in artificial urine. These results demonstrate the potential of combining the high sensitivity of nanostructured transducers with aptamer specificity to achieve ultrasensitive, selective, and cost-effective PCA3 detection suitable for point-of-care diagnostics. Optical measurements using TIRE, alongside other surface-characterisation methods such as AFM and SEM, provided complementary insights into binding kinetics, surface chemistry and aptamer-target interactions. Overall, this work establishes a robust foundation for ultrasensitive PCA3 detection, highlighting that aptamer‑based biosensors can provide simple, cost‑effective, non‑invasive, and highly specific diagnostic tools suitable for point‑of‑care diagnostics applications.
More Information
Statistics

Downloads

Downloads per month over past year

View more statistics

Metrics

Altmetric Badge

Dimensions Badge

Share
Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Actions (login required)

View Item View Item